Cargando…

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy

OBJECTIVE: To investigate feasibility, safety, and tolerability of long‐term (48 weeks) add‐on treatment with triheptanoin (UX007), the triglyceride of heptanoate, in adults with drug‐resistant epilepsy. METHODS: This extension study was offered to adult participants with drug‐resistant epilepsy who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borges, Karin, Kaul, Neha, Germaine, Jack, Carrasco‐Pozo, Catalina, Kwan, Patrick, O’Brien, Terence J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278596/ https://www.ncbi.nlm.nih.gov/pubmed/32524048 http://dx.doi.org/10.1002/epi4.12391

Ejemplares similares

Randomized trial of add‐on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy
por: Borges, Karin, et al.
Publicado: (2019)

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
por: O’Brien, Terence J., et al.
Publicado: (2020)

Cathodal transcranial direct‐current stimulation for treatment of drug‐resistant temporal lobe epilepsy: A pilot randomized controlled trial
por: Zoghi, Maryam, et al.
Publicado: (2016)

Triheptanoin: First Approval
por: Shirley, Matt
Publicado: (2020)

Correction to: Triheptanoin: First Approval
por: Shirley, Matt
Publicado: (2020)

Blended internet care for patients with severe mental illnesses: An open label prospective controlled cohort pilot study
por: Blankers, Matthijs, et al.
Publicado: (2016)

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study
por: Wechsler, Robert T, et al.
Publicado: (2014)

Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
por: Trinka, Eugen, et al.
Publicado: (2020)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020)

Preferences of young adults on the development of a new digital add-on alcohol intervention for depression treatment: A qualitative study
por: Schouten, Maria J.E., et al.
Publicado: (2023)

Open-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population
por: Haas, Julia W., et al.
Publicado: (2020)

Hippocampal Expression of Connexin36 and Connexin43 during Epileptogenesis in Pilocarpine Model of Epilepsy
por: Motaghi, Sahel, et al.
Publicado: (2017)

The utility of an automated and ambulatory device for detecting and differentiating epileptic and psychogenic non‐epileptic seizures
por: Naganur, Vaidehi D., et al.
Publicado: (2019)

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)
por: Rudà, Roberta, et al.
Publicado: (2020)

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
por: Wheless, James W., et al.
Publicado: (2021)

Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect
por: Hainque, Elodie, et al.
Publicado: (2019)

Intravenous Zoledronate 4 mg for the treatment of post-menopausal osteoporosis: A prospective open-labeled study
por: Arunthanachaikul, Thunyawarin, et al.
Publicado: (2021)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy
por: Silvennoinen, Katri, et al.
Publicado: (2019)

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study
por: Segal, Eric B., et al.
Publicado: (2021)

The MECP2‐TRD domain interacts with the DNMT3A‐ADD domain at the H3‐tail binding site
por: Kunert, Stefan, et al.
Publicado: (2023)

Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study
por: Hogan, Robert Edward, et al.
Publicado: (2020)

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
por: Zwiep, J.C., et al.
Publicado: (2022)

Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
por: Shim, Ji-Su, et al.
Publicado: (2022)

Collagenase clostridium histolyticum in patients with Dupuytren’s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes
por: Warwick, D., et al.
Publicado: (2015)

Validation of semi‐automated anatomically labeled SEEG contacts in a brain atlas for mapping connectivity in focal epilepsy
por: Taylor, Kenneth N., et al.
Publicado: (2021)

No effect of triheptanoin on exercise performance in McArdle disease
por: Madsen, Karen L., et al.
Publicado: (2019)

A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome
por: Striano, Pasquale, et al.
Publicado: (2022)

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
por: Voci, Davide, et al.
Publicado: (2023)

Perampanel and pregnancy
por: Vazquez, Blanca, et al.
Publicado: (2021)

Distribution of the CM-Dil-Labeled Human Umbilical Cord Vein Mesenchymal Stem Cells Migrated to the Cyclophosphamide-Injured Ovaries in C57BL/6 Mice
por: Jalalie, Ladan, et al.
Publicado: (2019)

A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
por: Berghuis, Bianca, et al.
Publicado: (2019)

Alterations in Cytosolic and Mitochondrial [U-(13)C]Glucose Metabolism in a Chronic Epilepsy Mouse Model
por: McDonald, Tanya S., et al.
Publicado: (2017)

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018)

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study
por: Thiele, Elizabeth, et al.
Publicado: (2019)

Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Tefera, Tesfaye W., et al.
Publicado: (2016)

Unravelling the brain networks driving spike‐wave discharges in genetic generalized epilepsy—common patterns and individual differences
por: Klamer, Silke, et al.
Publicado: (2018)

Instrumented reduction of a fixed C1–2 subluxation using occipital and C2/C3 fixation: A case report
por: Meals, Clifton, et al.
Publicado: (2013)

Effects of triheptanoin (UX007) in patients with long‐chain fatty acid oxidation disorders: Results from an open‐label, long‐term extension study
por: Vockley, Jerry, et al.
Publicado: (2020)

Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
por: French, Jacqueline A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0rar0tc6o22ljibqraldii2n0d